Roth: Lung Cancer 3rd edition

• 1 Smoking Cessation
• 2 Lung Cancer Susceptibility Genes
• 3 Lung Cancer Susceptibility and Risk Assessment Models
• 4 The Molecular Genetics of Lung Cancer
• 5 Molecular Biology of Preneoplastic Lesions of the Lung
• 6 Detection of Preneoplastic Lesions
• 7 Treatment of Preneoplastic Lesions of the Lung
• 8 The Pathology and Pathogenesis of Peripheral Lung Adenocarcinoma Including Bronchioloalveolar Carcinoma
• 9 Treatment of Bronchioloalveolar Carcinoma
• 10 Molecular Profiling for Early Detection and Prediction of Response in Lung Cancer
• 11 The Role for Mediastinoscopy in the Staging of Nonsmall Cell Lung Cancer
• 12 Minimally Invasive Surgery for Lung Cancer
• 13 Extended Resections for Lung Cancer
• 14 Adjuvant Chemotherapy Following Surgery for Lung Cancer
• 15 Induction Chemotherapy for Resectable Lung Cancer
• 16 Image-Guided Radiation Therapy
• 17 Stereotactic Body Radiation Therapy for Lung Cancer
• 18 Proton Therapy
• 19 Combinations of Radiation Therapy and Chemotherapy for Nonsmall Cell Lung Carcinoma
• 20 New Chemotherapeutic Agents in Lung Cancer
• 21 Immunologic Approaches to Lung Cancer Therapy
• 22 Epidermal Growth Factor Receptor Inhibitors
• 23 Tumor Angiogenesis: Biology and Therapeutic Implications for Lung Cancer
• 24 Retinoids and Rexinoids in Lung Cancer Prevention and Treatment
• 25 Proteasome Inhibition in Nonsmall Cell Lung Cancer Therapy
• 26 Targeted Genetic Therapy for Lung Cancer
• 27 Screening for Early Detection
• 28 Natural Agents for Chemoprevention of Lung Cancer
• Index

Lung Cancer 3rd edition by Jack A. Roth, James D. Cox and Waun Ki Hong explains an evidence-based approach to lung cancer management in depth. Comprehensive treatment guidelines are provided, the third edition of Lung Cancer explores vital issues such as:

• Lung cancer susceptibility and risk assessment.
• The pathology and pathogenesis of peripheral lung adenocarcinoma including bronchioloalveolar carcinoma.
• Screening for early detection.
• Advances in molecular and genetic markers.
• The detection and treatment of pre-neoplastic lesions and screening for lung cancer.
• Novel therapies such as angiogenesis and multi-tyrosine kinase inhibitors.

Lung Cancer is a concise summary of advances in lung cancer clinical research and treatment for the clinician and is an invaluable reference for respiratory physicians, medical oncologists, clinical and surgical oncologists.


About the Author

• Jack A. Roth, MD FACS, Professor and Chairman, Bud Johnson Clinical Distinguished Chair, The University of Texas M.D. Anderson Cancer Center, Department of Thoracic & Cardiovascular Surgery and Professor of Molecular and Cellular Oncology, Director, W.M. Keck Center for Cancer Gene Therapy, Houston, Texas, USA.
• James D. Cox, MD, Professor and Head, Division of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
• Waun Ki Hong, MD, American Cancer Society Clinical Research Professor, Charles A. LeMistre Distinguished Chair in Thoracic Oncology and Professor and Chairman, Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

Book Details

• Hardcover: 480 pages
• Publisher: Wiley-Blackwell; 3 edition (February 15, 2008)
• Language: English
• ISBN-10: 1405151129
• ISBN-13: 9781405151122
• Dimensions: 9.8 x 7.4 x 1.2 inches

List Price: $169.95 
 

Tags: Lung Cancer